Introduction {#S1}
============

The mechanisms involved in establishing the early heart and regulating its morphogenesis have been widely studied.^[@R1]^ During embryogenesis, the atrioventricular (A--V) canal and the sinu-atrial segment at the venous pole as well as the conotruncus at the arterial pole are added to the heart tube during tube looping.^[@R2],[@R3]^ Most of the cells that will differentiate into the developing myocardium are derived from a population of progenitor cells located in the pharyngeal mesoderm, termed the *secondary heart field* (SHF).^[@R4]--[@R6]^

Cells belongings to the pre-cardiac mesoderm will differentiate into early cardiac progenitors which can in turn differentiate into primitive cardiomyocytes, smooth muscle cells and endothelial cells.^[@R7]^ Known markers of pre-cardiac cells of the primary and the secondary heart field are Nkx2.5 and GATA-4.^[@R4]^ The expression of these two transcription factors is common to the LIM homeobox transcription factor positive (Isl-1^+^) cardiac progenitor cells (CPCs) and the developing pharyngeal mesoderm^[@R8]^ as well as foetal and postnatal mice hearts.^[@R9]^ This small number of Isl-1^+^ cells has been identified as a residue of the migrating SHF cells and may be considered resident progenitor cells in the myocardium in the post-natal age.^[@R10]^

With regard to the Isl-1^+^ cell distribution, Genead et al.^[@R11]^ described the frequency of Isl-1^+^ cells in the early first trimester human embryonic heart. They did not observe differences among the outflow tract, atria and right ventricle, confirming what had been previously reported for the late first and early second trimester.^[@R12]^ Clusters of Isl-1^+^ cells were identified in the right atrial wall of foetal and new born hearts, whereas occasional Isl-1^+^ cells have been found in the ventricular regions.^[@R13]^ Isl-1 has been identified as a marker of CPCs in the adult rat heart,^[@R14],[@R15]^ giving support to the hypothesis that some cells from the embryo may also persist into adulthood.^[@R16]^

Most studies concerning the localisation of CPCs in the developing heart have been performed in mice or chicks. The localisation and identification of CPCs in the human foetal and adult heart has been investigated for the first time by Limana and colleagues,^[@R17]^ with their analysis limited to epicardium and CD34^+^ or c-Kit^+^ cells. Cells expressing c-Kit were identified also in the human foetal and post-natal myocardium specimens. These cells were located within the connective tissue and within muscle bundles. Their number declined over time until the first post-natal month.^[@R18]^

The transmembrane receptor tyrosine kinase c-Kit is expressed on the cell surface of stem cells during haematopoiesis,^[@R19]^ dental pulp stem cells originating from the neural crest cells,^[@R20]^ in the developing pancreas^,[@R21]^ and recently as been proposed as a useful marker to differentiate primary melanoma from compound nevi.^[@R22]^ Apart from the many studies on the expression and localization of this receptor, c-Kit has been proposed also as the most important marker for adult CPCs.^[@R23],[@R24]^ The first isolation and characterisation of adult human CPCs has been performed from percutaneous right ventricular endocardial biopsy specimens by Smith and colleagues.^[@R25]^ Multipotent CPCs from human cardiospheres consistently expressed c-Kit and CD105, the regulatory component of the transforming growth factor-β receptor complex that is important in angiogenesis^[@R26]^ and haematopoiesis.^[@R27]^ Therefore, it seems that c-Kit^+^ cells are CPCs homing the myocardium in the adulthood, while Isl-1^+^ cells have been proposed as a different subset of undifferentiated cells able to generate endothelial cells, cardiomyocytes, smooth muscle cells and cardiac fibroblasts but present only in the developing heart and persisting in the post-natal age.^[@R8],[@R28],[@R29]^ In the mean time another subset of cardiac undifferentiated cells (epicardial progenitors) has been identified which barely participate in atria, right ventricle and outflow tract formation and that are detectable in the murine and human foetal, but not adult hearts.^[@R30]^ In the present study, we analysed human hearts from embryos, foetuses and neonates at different gestational ages to determine the presence and co-localization of the Isl-1^+^ CPCs identified *in the embryonic and postnatal* heart, and the c-Kit^+^/CD105^+^ cells described *in the adult* heart, to understand if the c-Kit^+^ cells abundantly isolated from adult hearts are present also in the embryonic and foetal heart and if they are a different subset of the extensively studied Isl-1^+^ cells.

Materials and Methods {#S2}
=====================

Human cardiac samples
---------------------

Cardiac tissue samples, comprising the endocardial, myocardial, and epicardial layers of the ventricles, were obtained by autopsy from embryos, foetuses, preterm infants, and term infants and collected, after written consent from the mother, in the Department of Human Pathology of the University of Messina, Italy. The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975. The Ethics Committee of the University of Messina approved the study.

Gestational age of the foetuses ranged between 9 and 40 weeks, as shown in [Table 1](#T1){ref-type="table"} and [Table 2](#T2){ref-type="table"}. Specifically, our cohort comprised 25 samples. The causes related to the death of the analysed foetuses and of the preterm and term infants are shown in [Table 1](#T1){ref-type="table"} and [Table 2](#T2){ref-type="table"}. Autopsies and sample collections were carried out immediately after delivery with less than a 24-hour interval since foetal death had occurred.

Table 1Clinical and morphological data and c-Kit/CD105 expression in 1 embryo, 12 foetuses, 1 preterm infant and 1 term infant.Case No.TrimesterGestational age (wks)Age at deathCause of deathHeart malformationsCardiomyocytesEndocardiumIntestitial cellsEmbryo 1I99 wksVTEndocardial cushion defect (AVC of the heart)c-Kit+CD105+c-Kit+/CD105Foetuses 2I1313 wksSA for chorioamnionitisAbsentc-Kit+CD105+c-Kit+/CD105− 3II1414 wksTA for CRSVSDc-Kit +CD105+c-Kit+/CD105− 4II1414 wksSA for chorioamnionitisAbsentc-Kit+CD105+c-Kit+/CD105− 5II1414 wksTA for cerebral malformationsAbsentc-Kit+CD105+c-Kit+/CD105− 6II1515 wksSA for chorioamnionitisAbsentc-Kit+CD105+c-Kit+/CD105− 7II1616 wksSA for abruption placentaeAbsentc-Kit+CD105+c-Kit+/CD105− 8II1717 wksTA for cerebral malformationsAbsentc-Kit+/−CD105+c-Kit+/CD105+ 9II1818 wksTA for MCAAbsentc-Kit+/−CD105+c-Kit+/ CD105+ 10II1919 wksTA for PKD, UBH, CLGP left, PEV bilateralAbsentc-Ki+/−CD105+c-Kit +/CD105+ 11II2222 wksSA for chorioamnionitisAbsentc-Kit+/−CD105+c-Kit +/CD105+ 12II2222 wksSA for chorioamnionitisAbsentc-Kit −CD105+c-Kit +/CD105+ 13III2727 wksSA for abruption placentaeAbsentc-Kit −CD105+c-Kit +/CD105+Preterm infant 14III361 dayRespiratory failureAbsentc-Kit −CD105+c-Kit +/CD105+Term infant 15III406 yrsDisseminate intravascular coagulationAbsentc-Kit −CD105+c-Kit +/CD105+[^3]

Table 2Clinical and morphological data and number of Isl-1 positive cells per area (mm^2^) in 7 foetuses, 2 preterm infants and 1 term Infant.Case No.TrimesterGestational age (wks)Age at deathCause of deathGrowth defectsHeart malformationsSection area (mm^2^)Isl-1+ cells/mm^2^ × 10^[@R4]^[\*](#TF2-1){ref-type="table-fn"}Foetuses 16II1414 wksAbruptio placentaeAbsentAbsent56171.5±11561.464.523±1.22 17II1515 wksTA for Prune-Belly syndromeAbsentAbsent46063±3055.723.543±0.15 18II1616 wksTA for trisomy 21IUGRAbsent83666.33±2011.761.394±0.17 19II1919 wksTA for trisomy 21AbsentAbsent71642.66±4190.291.141±0.62 20II2020 wksTA for trisomy 21AbsentAbsent186604.66±90180.735±0.10 21II2121 wksTA for trisomy 21AbsentAbsent119550.33±4100.160.889±0.14 22II2222 wksTA for cerebral malformationsAbsentAbsent162438±7750.210.738±0.02Preterm infants 23III268 daysRespiratory failure hypertrophyIUGRVentricular septal101629±1409.491.279±0.08 24III362 hrsSepsisAbsentVentricular septal hypertrophy165575.33±2524.220.664±0.05Term infants 25III408 hrsRespiratory failureAbsentAbsent202609±13666.330.548±0.12[^4][^5]

All samples were fixed in 10% formalin and embedded in paraffin for morphological diagnostic evaluation (haematoxylin/eosin) and immunohistochemistry.

Immunohistochemistry
--------------------

Single immunohistochemistry was performed by a streptavidin-biotin complex method using LSAB2 kit (DAKO Co., Carpinteria, CA, USA). After deparaffination and rehydration, the tissue sections were incubated with the protein blocking agent (DAKO) for 10 min and the primary antibody for 1 h. We used the anti-Isl-1 antibody (1:200, rabbit polyclonal, AB5754, Chemicon Int., Millipore Corp., Billerica, MA, USA). The linked primary antibody was detected with DAKO LSAB2 streptavidin-peroxidase system according to manufacturer\'s instructions. 3-Amino-9-ethylcarbazole (AEC) was used as a chromogen, whereas hematoxylin was used as a light counterstain.

Double immunohistochemistry was performed by a streptavidin-biotin complex for the goat polyclonal antibody (CD105) and labelled using polymer-alkalyne phosphatase (AP) for the rabbit polyclonal antibody (c-Kit). After deparaffination and rehydration the tissue sections were incubated with the Peroxidase Block solution (Vector Laboratories Inc., Burlingame, CA, USA) for 5 min, washed in PBS for 5 min, and incubated with the anti-CD105 goat polyclonal antibody (1:50, SC-19793, Santa Cruz Biotechnology Inc., Santa Cruz, CA) for 30 min. After washing in PBS, sections were incubated with the biotinylated anti-goat secondary antibody (1:200, SC-2774, Santa Cruz Biotechnology Inc.) for 30 min, and washed again in PBS. For the antibody detection the streptavidin-HRP complex (LSAB2 kit DAKO) was used for 10 min. Sections were then rinsed in PBS with 0.1% Tween 20 (T-PBS) for 5 min, and incubated with 3,3′-Diaminobenzidine (DAB--Vector Laboratories) as the HRP-substrate.

After the detection of the first antigen, sections were incubated with the Doublestain Block solution (Vector Laboratories) for 3 min, washed in T-PBS for 5 min, and incubated with the anti-c-Kit rabbit polyclonal antibody (1:200, KAP-TK005, Stressgen Bioreagents, Ann Arbor, MI, USA) for 30 min. After washing with T-PBS for 5 min, sections were incubated with a labelled polymer -- AP secondary antibody (Vector Laboratories) for 30 min, and washed again. Fast red (Vector Laboratories) was used as the AP substrate for 5 min. Sections were then washed in tap water and counterstained with hematoxylin for 1 min. DAKO Aqueous mounting medium was used. Each tissue section was analysed by two independent observers (CS and PC) who evaluated the number of positive cells in three paraffin embedded sections independently stained.

To analyse the number of Isl-1 positive cells the area of each section was determined. It was taken a 100%-600dpi picture of each stained slide using an Epson Perfection 1200 Scanner connected to a personal computer. The section sizes were too big to be measured with pictures taken at the microscope. Each picture was then converted to an 8-bit picture, Brightness was adjusted and Threshold applied. On the Threshold pictures the *Analyze particles* function of the ImageJ Software (released by the NIH, *<http://rsbweb.nih.gov/ij/>*) was applied to measure the area of the coloured sections. Data are shown in [Table 2](#T2){ref-type="table"}. An example of the area measurement is shown in Appendix [Figure 1](#F1){ref-type="fig"}.

Figure 1Identification of interstitial c-Kit+/CD105+ and Isl-1+ cells in human foetal and infant hearts before (A--D) and after (E--G) the 17th gestational week. A, B, C) c-Kit (Fast Red) and CD105 (DAB) double immunostaining in a 16-week foetal heart. E, F) c-Kit (Fast Red) and CD105 (DAB) double immunostaining in a preterm infant (36 weeks of gestation, E) and in a term infant (6-year-old child. F) Black arrows indicate double stained cells. D) Isl-1 (AEC) single immunostaining in a 14-week foetal heart; red arrows indicate Isl-1 positive cells. G) Isl-1 (AEC) single immunostaining in a 21-week foetal heart. Double positive cells appeared deep red; red arrow indicate Isl-1 positive cells.

Immunofluorescence
------------------

After deparaffination and rehydration, tissue sections were blocked with 5% BSA in PBS for 30 min and incubated with the first primary antibody overnight, one night for each antibody (1:50, anti-c-Kit, KAP-TK005, Stressgen Bioreagents; 1:50, anti-Isl-1, goat polyclonal, SC-23590, Santa Cruz Biotechnology Inc.). After washing with PBS, cells were further incubated with fluorescent secondary antibodies 1 h at room temperature (1:50, TRITC-conjugated anti-rabbit secondary antibody, T5268, Sigma-Aldrich, St. Louis, MO; 1:50 FITC-conjugated donkey anti-goat secondary antibody, SC-2024, Santa Cruz Biotechnology Inc.). In single immunofluorescence experiments nuclei were stained 10 min with 10 µg/mL Hoechst33342 staining in PBS (Invitrogen Corp., Carlsbad, CA, USA). In confocal experiments nuclei were stained 15 min with 1 µM Toto-3 staining in PBS (T3604, Invitrogen Corp.). To avoid cross-reactions, sections were incubated with goat-anti-Isl-1 first and with rabbit anti-c-Kit after, and with donkey anti-goat first and goat anti-rabbit after, in four different incubations.

To avoid autofluorescence of paraffin/formalin embedded sections, the samples were incubated in 0.1% Sudan Black in 70% ethanol for 5 min after nuclei staining.^[@R31]^ For imaging they were both used a Zeiss LSM5 Exciter Laser Scanning Confocal Microscope and a Leica CTR5000 fluorescent microscope. During confocal microscope observations all parameters for picture acquisition were kept the same and automatically saved.

Statistical analysis
--------------------

Data are shown as mean values and the standard deviation has been calculated. The hypothesis that the number of Isl-1^+^ cells per mm^2^ varied with the gestational age was tested using a t-test of dependent samples (P\<0.05). The hypothesis that there was a linear correlation between the gestational age of the foetuses and the number of Isl-1^+^ cells per mm^2^ was tested using the Pearson coefficient (P\<0.05). For the statistical analysis it was used the STATISTICA 6.0 software (StatSoft Italia srl, Vigonza, Italy).

Results {#S3}
=======

Expression of c-Kit on the membrane of cardiomyocytes of foetal hearts
----------------------------------------------------------------------

To study the localization of c-Kit^+^ CPCs previously isolated and characterized in the rat adult heart by our research group,^[@R14]^ we performed immunohistochemistry and immunofluorescence experiments on heart samples from embryonic and foetal human hearts.

As shown in [Table 1](#T1){ref-type="table"} and [Figure 1](#F1){ref-type="fig"} A--C, many interstitial and subepicardial cells and all cardiomyocytes were positive for c-Kit from the 9^th^ to the 17^th^ week of gestation, and sometimes also to the 22^nd^ week.

The expression of c-Kit on the surface of cardiomyocytes of the first and second gestational trimesters was confirmed by immunofluorescence experiments ([Figure 2](#F2){ref-type="fig"} A, F). In the only embryonic sample (9^th^ gestational week) some structures similar to the primordial myocardium of the cardiac tube were clearly positive to c-Kit ([Figure 2](#F2){ref-type="fig"} B--C). Later on during gestation, clusters of c-Kit^+^ cells were present ([Figure 2](#F2){ref-type="fig"} D).

Figure 2Expression of c-Kit and Isl-1 in embryonic and foetal hearts. A) Expression of c-Kit in a 16-week foetal heart. B, C) Expression of c-Kit in a 9-week human embryo. D) A cluster of c-Kit+ cells in a 15-week foetal heart. E) Co-localization of c-Kit+ and Isl-1+ cells in a 14-week foetal heart; white arrows indicate cells double positive for Isl-1 and c-Kit. F) Confocal microscopy analysis of the expression of c-Kit and Isl-1 in the myocardium of a 16-week foetal heart.

Immunolocalisation of cardiac progenitor cells
----------------------------------------------

In literature there have been clearly identified two main populations of cardiac progenitor cells: human cells double positive for c-Kit and CD105 in adult hearts by Smith *et al.*,^[@R25]^ and cells positive for Isl-1 by Laugwitz *et al.*^[@R9]^ in the developing heart. To localize separately the two populations in the human foetal hearts we performed a double immunostaining for c-Kit and CD105, and a single immunostaining for Isl-1. Results were summarised in Table 1 for c-Kit/CD105 and [Table 2](#T2){ref-type="table"} for Isl-1.

Interstitial c-Kit^+^/CD105^+^ cells appeared at the 17^th^ gestational week and persisted after birth, as shown in [Table 1](#T1){ref-type="table"} and [Figure 1](#F1){ref-type="fig"} E--F. These double positive cells were localised only in the myocardium and were never localised inside capillaries. Many dividing cells were identified in the myocardium ([Figure 1](#F1){ref-type="fig"}F). There were no differences between normal hearts and foetuses with heart malformations ([Table 1](#T1){ref-type="table"}).

From the 9^th^ to the 16^th^ gestational week, they were present only c-Kit^+^ (in the subepicardial space, [Figure 1](#F1){ref-type="fig"}A, and in the myocardium, [Figure 1](#F1){ref-type="fig"}C) or CD105^+^ cells (endocardium and endothelium, [Figure 1](#F1){ref-type="fig"}B). Isl-1^+^ cells were present in the myocardium and in the suben-docardium, with no differences between right and left ventricles. Groups of Isl-1^+^ cells were sometimes visible, with a number ranging between 4.523±1.22×10^[@R4]^ at the 14th gestational week and 0.548±0.12×10^[@R4]^ per mm^2^ in the post-natal age ([Table 2](#T2){ref-type="table"}, [Figure 1](#F1){ref-type="fig"} D,G). The t-test for dependent variables demonstrated that the decrease in the number of Isl-1^+^ cells was significant and that this difference depended on the gestational week. The number of Isl-1^+^ cells was higher between the 14^th^ and the 16--19^th^ gestational weeks and it was almost the same between the 20^th^ gestational week and the post-natal age. The Pearson coefficient (r=0.5; P=0.14) demonstrated that there was not a linear correlation between the gestational week and the number of cells per mm^2^.

Colocalization of c-Kit /Isl-1 cells
------------------------------------

To study whether these markers were labelling the same or a different cell population, we evaluated the co-expression of c-Kit and Isl-1. We found that all the interstitial and subendocardial Isl-1^+^ cells were positive for c-Kit ([Figure 2](#F2){ref-type="fig"}E), while not all the cells positive for c-Kit were Isl-1^+^ (Appendix [Figure 2](#F2){ref-type="fig"}). Cardiomyocytes were positive only for c-Kit ([Figure 2](#F2){ref-type="fig"}F). The co-localization of the expression of c-Kit and Isl-1 on the same cell was confirmed by confocal microscopy (Appendix Figure 3).

Discussion {#S4}
==========

In this study we described the localization and the temporal distribution of c-Kit^+^/CD105^+^ and Isl-1^+^ cells from the embryonic to the post-natal heart, and we tested the hypothesis if c-Kit^+^ cells abundantly isolated from adult hearts were also present in the embryonic and foetal heart and if they represented a subset of cells different from the Isl-1^+^ cell population.

Cardiac precursors can be isolated from adult and post-natal hearts,^[@R9],[@R32]^ and are characterized by several markers among which c-Kit both in foetal^[@R17]^ and adult heart,^[@R16]^ Isl-1 in early cardiogenesis,^[@R9],[@R28]^ and CD105 in human endomyocardial biopsy specimens.^[@R25]^

With regard to these three CPC markers, the present study shows that Isl-1^+^ cells are present in the human hearts in foetuses, preterm infants and term infants, that their number decreases with the gestational week particularly after the 16--19^th^ gestational week, and that there is a difference in the temporal distribution of c-Kit^+^ cells. These data also show that cardiomyocytes and some interstitial cells are c-Kit^+^ from the 9^th^ to the 16^th^--19^th^ gestational weeks, and that after this time period, only a few interstitial cells express c-Kit. Interstitial cells, which express both c-Kit and CD105 on their surfaces, are present only from the 17^th^ week to the 6th year of age. The presence of c-Kit^+^/CD105^+^ cells in the different stages of gestation does not demonstrate that c-Kit^+^ cells are resident cardiac cells. But the fact that many structures in the embryonic heart and foetal cardiomyocytes are positive to c-Kit in the early weeks of gestation provides evidence that c-Kit^+^ cells are present in the heart from the early stages of cardiogenesis, and their number decreases during gestation until the postnatal age.

We also demonstrated that the interstitial and subendocardial Isl-1^+^ cells are positive also to c-Kit. The co-localization of the two CPC markers let us suppose that Isl-1^+^ cells are a subset of the c-Kit^+^ CPCs population usually isolated and identified in the adult heart.

The hypothesis that c-Kit^+^ human CPCs are more abundant in the early stages of gestation and that their number decreases over time is supported by a recent paper, where the authors isolated and grown human CPCs from neonate and infant specimens.^[@R33]^ The c-Kit^+^ cells that the authors isolated and expanded were also positive to Isl-1 in culture inside cardiospheres, supporting our hypothesis that the postnatal Isl-1^+^ cells may be a subpopulation of c-Kit^+^ human CPCs, which originate from the embryonic pre-cardiac mesoderm and probably persist in the adulthood.

In conclusion, we have demonstrated that foetal cardiomyocytes are positive to c-Kit, and that foetal Isl-1^+^ cells are a subset of foetal c-Kit^+^ CPCs. A better understanding of the localisation and migration of CPCs during cardiogenesis may be achieved using mouse or zebrafish transgenic models.
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